Alexandria Real Estate Equities
ARE
#2383
Rank
A$10.98 B
Marketcap
A$63.06
Share price
-2.60%
Change (1 day)
-44.41%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2026 (TTM): -A$0.95 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are A$2.85 Billion. In 2025 the company made an earning of -A$1.39 Billion a decrease over its 2024 earnings that were of A$0.97 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.95 Billion-31.87%
2025 -A$1.39 Billion-242.13%
2024 A$0.97 B96.11%
2023 A$0.49 B-53.56%
2022 A$1.07 B-3.96%
2021 A$1.11 B-20.26%
2020 A$1.40 B72.88%
2019 A$0.81 B3.11%
2018 A$0.78 B73.54%
2017 A$0.45 B464.88%
2016 A$80.14 M-77.32%
2015 A$0.35 B36.31%
2014 A$0.25 B-10.81%
2013 A$0.29 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
A$14.85 B-1,817.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.64 B-5,147.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.74 B-1,573.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$13.73 B-1,688.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.62 B-288.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.45 B-1,656.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$1.21 B-241.04%๐Ÿ‡บ๐Ÿ‡ธ USA